Showing results 1 to 20 of 40
next >
| Issue Date | Title | Author(s) |
| 2016-07 | A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease. | Haw, TJ; Starkey, MR; Nair, PM; Pavlidis, S; Liu, G; Nguyen, DH; Hsu, AC; Hanish, I; Kim, RY; Collison, AM; Inman, MD; Wark, PA; Foster, PS; Knight, DA; Mattes, J; Yagita, H; Adcock, IM; Horvat, JC; Hansbro, PM |
| 2022-10 | Airway and parenchymal transcriptomics in a novel model of asthma and COPD overlap. | Tu, X; Kim, RY; Brown, AC; de Jong, E; Jones-Freeman, B; Ali, MK; Gomez, HM; Budden, KF; Starkey, MR; Cameron, GJM; Loering, S; Nguyen, DH; Nair, PM; Haw, TJ; Alemao, CA; Faiz, A; Tay, HL; Wark, PAB; Knight, DA; Foster, PS; Bosco, A; Horvat, JC; Hansbro, PM; Donovan, C |
| 2017-06-02 | Allergen-encoding bone marrow transfer inactivates allergic T cell responses, alleviating airway inflammation. | Al-Kouba, J; Wilkinson, AN; Starkey, MR; Rudraraju, R; Werder, RB; Liu, X; Law, S-C; Horvat, JC; Brooks, JF; Hill, GR; Davies, JM; Phipps, S; Hansbro, PM; Steptoe, RJ |
| 2012-08-01 | Chlamydia muridarum lung infection in infants alters hematopoietic cells to promote allergic airway disease in mice | Starkey, MR; Kim, RY; Beckett, EL; Schilter, HC; Shim, D; Essilfie, AT; Nguyen, DH; Beagley, KW; Mattes, J; Mackay, CR; Horvat, JC; Hansbro, PM |
| 2021 | Cord blood group 2 innate lymphoid cells are associated with lung function at 6 weeks of age. | Martins Costa Gomes, G; de Gouveia Belinelo, P; Starkey, MR; Murphy, VE; Hansbro, PM; Sly, PD; Robinson, PD; Karmaus, W; Gibson, PG; Mattes, J; Collison, AM |
| 2020-04-23 | Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma. | Ali, MK; Kim, RY; Brown, AC; Mayall, JR; Karim, R; Pinkerton, JW; Liu, G; Martin, KL; Starkey, MR; Pillar, AL; Donovan, C; Pathinayake, PS; Carroll, OR; Trinder, D; Tay, HL; Badi, YE; Kermani, NZ; Guo, Y-K; Aryal, R; Mumby, S; Pavlidis, S; Adcock, IM; Weaver, J; Xenaki, D; Oliver, BG; Holliday, EG; Foster, PS; Wark, PA; Johnstone, DM; Milward, EA; Hansbro, PM; Horvat, JC |
| 2020-10-26 | Differences in pulmonary innate lymphoid cells are dependent on mouse age, sex and strain | Loering, S; Cameron, GJM; Bhatt, NP; Belz, GT; Foster, PS; Hansbro, PM; Starkey, MR |
| 2016-07-01 | Elucidating novel disease mechanisms in severe asthma | Kim, RY; Rae, B; Neal, R; Donovan, C; Pinkerton, J; Balachandran, L; Starkey, MR; Knight, DA; Horvat, JC; Hansbro, PM |
| 2019-05-01 | Emerging therapeutic potential of group 2 innate lymphoid cells in acute kidney injury | Cameron, GJM; Jiang, SH; Loering, S; Deshpande, AV; Hansbro, PM; Starkey, MR |
| 2019-01-01 | Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease | Nair, PM; Starkey, MR; Haw, TJ; Liu, G; Collison, AM; Mattes, J; Wark, PA; Morris, JC; Verrills, NM; Clark, AR; Ammit, AJ; Hansbro, PM |
| 2021-07-12 | Environmental Air Pollutants Inhaled during Pregnancy Are Associated with Altered Cord Blood Immune Cell Profiles | Martins Costa Gomes, G; Karmaus, W; Murphy, VE; Gibson, PG; Percival, E; Hansbro, PM; Starkey, MR; Mattes, J; Collison, AM |
| 2019-01-01 | Group 2 innate lymphoid cells are redundant in experimental renal ischemia-reperfusion injury | Cameron, GJM; Cautivo, KM; Loering, S; Jiang, SH; Deshpande, AV; Foster, PS; McKenzie, ANJ; Molofsky, AB; Hansbro, PM; Starkey, MR |
| 2019-07-01 | IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis | Starkey, MR; Plank, MW; Casolari, P; Papi, A; Pavlidis, S; Guo, Y; Cameron, GJM; Haw, TJ; Tam, A; Obiedat, M; Donovan, C; Hansbro, NG; Nguyen, DH; Nair, PM; Kim, RY; Horvat, JC; Kaiko, GE; Durum, SK; Wark, PA; Sin, DD; Caramori, G; Adcock, IM; Foster, PS; Hansbro, PM |
| 2019-04-01 | Lung development and emerging roles for type 2 immunity | Loering, S; Cameron, GJM; Starkey, MR; Hansbro, PM |
| 2019 | Lung development and emerging roles for type 2 immunity | HANSBRO, PM; Loering, S; Cameron, GJM; Starkey, MR |
| 2015-05 | Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma. | Essilfie, A-T; Horvat, JC; Kim, RY; Mayall, JR; Pinkerton, JW; Beckett, EL; Starkey, MR; Simpson, JL; Foster, PS; Gibson, PG; Hansbro, PM |
| 2017-07-01 | Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma | Hansbro, PM; Kim, RY; Starkey, MR; Donovan, C; Dua, K; Mayall, JR; Liu, G; Hansbro, NG; Simpson, JL; Wood, LG; Hirota, JA; Knight, DA; Foster, PS; Horvat, JC |
| 2017-04-06 | MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD | Hsu, ACY; Dua, K; Starkey, MR; Haw, TJ; Nair, PM; Nichol, K; Zammit, N; Grey, ST; Baines, KJ; Foster, PS; Hansbro, PM; Wark, PA |
| 2017-02-01 | MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2 | Kim, RY; Horvat, JC; Pinkerton, JW; Starkey, MR; Essilfie, AT; Mayall, JR; Nair, PM; Hansbro, NG; Jones, B; Haw, TJ; Sunkara, KP; Nguyen, TH; Jarnicki, AG; Keely, S; Mattes, J; Adcock, IM; Foster, PS; Hansbro, PM |
| 2016-01-11 | The MIF antagonist ISO-1 attenuates corticosteroid-insensitive inflammation and airways hyperresponsiveness in an ozone-induced model of COPD | Russell, KE; Chung, KF; Clarke, CJ; Durham, AL; Mallia, P; Footitt, J; Johnston, SL; Barnes, PJ; Hall, SR; Simpson, KD; Starkey, MR; Hansbro, PM; Adcock, IM; Wiegman, CH |
